Fig. 6

MENA knockdown promotes tamoxifen resistance in the HR⁺ breast cancer cells via AKT signaling pathway. Western blot analysis shows MENA, AKT, p-AKT (Ser473) and β-actin protein levels in the control and MENA-silenced T47D and MCF7 treated with or without 4-OHT cells